Kodiak Sciences (KOD) Equity Average (2018 - 2026)

Kodiak Sciences has reported Equity Average for 9 years, with the latest figure at $134.7 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 4.0% year-over-year to $134.7 million; the trailing twelve-month figure through Mar 2026 stood at $134.7 million (up 4.0% YoY), and the FY2025 full-year result was $153.8 million, down 26.05% from the prior year.
• Equity Average for Q1 2026 stood at $134.7 million, up from $90.5 million in the prior quarter.
• The five-year high for Equity Average was $630.4 million in Q1 2022, with the low at $47.0 million in Q3 2025.
• Historically, Equity Average has averaged $287.2 million across 5 years, with a median of $253.5 million in 2024.
• Annual changes were most pronounced in 2025 — Equity Average tumbled 76.5% — and 2026, when it advanced 4.0%.
• Kodiak Sciences' Equity Average stood at $457.8 million in 2022, then tumbled by 37.95% to $284.1 million in 2023, then slumped by 40.93% to $167.8 million in 2024, then tumbled by 46.05% to $90.5 million in 2025, then jumped by 48.82% to $134.7 million in 2026.
• The last three Equity Average figures came in at $134.7 million (Q1 2026), $90.5 million (Q4 2025), and $47.0 million (Q3 2025), per Business Quant data.